How to buy Medicenna Therapeutics Corp (MDNA) stocks

Medicenna Therapeutics Corp is a biotechnology business based in Canada. Medicenna Therapeutics Corp shares (MDNA) are listed on the Toronto Stock Exchange (TSX) and all prices are listed in Canadian Dollars.

Its last market close was C$1.71 – a decrease of 3.39% over the previous week. Medicenna Therapeutics Corp employs 16 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Medicenna Therapeutics Corp stock

Buy Medicenna Therapeutics Corp stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

Medicenna Therapeutics Corp stock price (Toronto Stock Exchange (TSX): MDNA)

Use our graph to track the performance of MDNA stocks over time.

Medicenna Therapeutics Corp stocks at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	C$1.71
52-week range	C$0.39 - C$2.98
50-day moving average more info button	C$1.99
200-day moving average more info button	C$2.03
Wall St. target price	C$4.38
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	C$-0.38

Is it a good time to buy Medicenna Therapeutics Corp stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Medicenna Therapeutics Corp price performance over time

Historical closes compared with the close of C$1.71 from 2024-12-20

1 week (2024-12-13)	-3.39%
1 month (2024-11-22)	8.92%
3 months (2024-09-20)	-15.76%
6 months (2024-06-21)	-8.56%

1 year (2023-12-22)	307.14%
2 years (2022-12-22)	180.33%
3 years (2021-12-22)	2.19
5 years (2019-12-20)	2.62

Medicenna Therapeutics Corp financials

Gross profit TTM	C$0
Return on assets TTM	-32.8%
Return on equity TTM	-105.43%
Profit margin	0%
Book value	C$0.08
Market Capitalization more info button	C$136.8 million
EBITDA more info button	C$-18,247,000

TTM: trailing 12 months

Medicenna Therapeutics Corp stock dividends

We're not expecting Medicenna Therapeutics Corp to pay a dividend over the next 12 months.

Have Medicenna Therapeutics Corp's stocks ever split?

Medicenna Therapeutics Corp's stocks were split on a 1:14 basis on 2 March 2017 . So if you had owned 14 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Medicenna Therapeutics Corp stocks – just the quantity. However, indirectly, the new 1300% higher stock price could have impacted the market appetite for Medicenna Therapeutics Corp stocks, which in turn could have impacted Medicenna Therapeutics Corp's stock price.

Medicenna Therapeutics Corp stock price volatility

Over the last 12 months, Medicenna Therapeutics Corp's stocks have ranged in value from as little as C$0.385 up to C$2.98. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (TO average) beta is 1, while Medicenna Therapeutics Corp's is 1.189. This would suggest that Medicenna Therapeutics Corp's stocks are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Medicenna Therapeutics Corp overview

Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops bizaxofusp (MDNA55), an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a masked bi-functional anti-PD1-IL2 Superkine for various solid tumors; and MDNA132, an IL-13 Superkine for various tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, inhibitors, antibodies, cytokines, or other Superkines Medicenna Therapeutics Corp. is headquartered in Toronto, Canada..

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of Medicenna Therapeutics Corp is owned by insiders or institutions?
Currently 22.068% of Medicenna Therapeutics Corp stocks are held by insiders and 12.773% by institutions. How many people work for Medicenna Therapeutics Corp?
Latest data suggests 16 work at Medicenna Therapeutics Corp. When does the fiscal year end for Medicenna Therapeutics Corp?
Medicenna Therapeutics Corp's fiscal year ends in March. Where is Medicenna Therapeutics Corp based?
Medicenna Therapeutics Corp's address is: 2 Bloor Street West, Toronto, ON, Canada, M4W 3E2 What is Medicenna Therapeutics Corp's ISIN number?
Medicenna Therapeutics Corp's international securities identification number is: CA58490H1073

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.